Cargando…

BQ-AurIPr: a redox-active anticancer Au(i) complex that induces immunogenic cell death

Immunogenic Cell Death (ICD) is a unique cell death mechanism that kills cancer cells while rejuvenating the anticancer immunosurveillance, thereby benefiting the clinical outcomes of various immuno-chemotherapeutic regimens. Herein, we report development of a library of benzo[a]quinolizinium-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mule, Ravindra D., Kumar, Akhilesh, Sancheti, Shashank P., Senthilkumar, B., Kumar, Himanshu, Patil, Nitin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491088/ https://www.ncbi.nlm.nih.gov/pubmed/36320699 http://dx.doi.org/10.1039/d2sc03756d

Ejemplares similares

IPR 2021
Publicado: (2021)

Aur. Cor. Celsus on Medicine
Publicado: (1837)

iPRES 2018
Publicado: (2018)

IPR, biosafety, and bioethics
por: Goel, Deepa, et al.
Publicado: (2013)

Evaluation of temperature rise in the pulp during various IPR techniques—an in vivo study
por: Banga, Kiran, et al.
Publicado: (2020)

Swasthya Aur Rog. (Health and Disease)
Publicado: (1933)

IPR{reg} : identificación del paciente en riesgo /
Publicado: (2013)

Advocacy and IPR, tutorial 4
por: Gleig, Morag
Publicado: (2005)

P740: PK, PD AND SAFETY OF FIRST-IN-HUMAN, FIRST-IN-CLASS PHASE I TRIAL (AUR103-101; BHARAT) OF AUR103, AN ORAL CD47 INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES
por: Krishnappa, Manjunath, et al.
Publicado: (2023)

IPR Issues and High Quality Genetic Testing
por: Van Overwalle, Geertrui
Publicado: (2010)

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines
por: Li, Dedong, et al.
Publicado: (2023)

Comparison of the catalytic activity for the Suzuki–Miyaura reaction of (η(5)-Cp)Pd(IPr)Cl with (η(3)-cinnamyl)Pd(IPr)(Cl) and (η(3)-1-t-Bu-indenyl)Pd(IPr)(Cl)
por: Melvin, Patrick R, et al.
Publicado: (2015)

M. Charcot on Menière's Disease, or Vertigo ab Aure Læsâ
Publicado: (1874)

Brazilian Urologist's mental health aspects auring the Covid-19 pandemic
por: da Silva, Aline Gularte Teixeira, et al.
Publicado: (2020)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

IPR-Gesetze in Europa: Textausgabe in Originalsprachen mit deutschen Übersetzungen
por: Riering, Wolfgang
Publicado: (1997)

IPr# – highly hindered, broadly applicable N-heterocyclic carbenes
por: Zhao, Qun, et al.
Publicado: (2021)

Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?
por: Varghese, Ryan, et al.
Publicado: (2023)

1014. Decreasing Antimicrobial Use by 25% via Submission to NHSN-AUR Module
por: Kassamali, Zahra, et al.
Publicado: (2019)

Synergistic Microbicidal Effect of AUR and PEITC Against Staphylococcus aureus Skin Infection
por: Chen, Haoran, et al.
Publicado: (2022)

Editorial: Combating Redox Imbalance-Associated Complications With Natural Products
por: Pandey, Abhay K., et al.
Publicado: (2021)

Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook – an update
por: Akash, Shopnil, et al.
Publicado: (2023)

Computational Study of Mechanism and Thermodynamics of Ni/IPr-Catalyzed Amidation of Esters
por: Ji, Chong-Lei, et al.
Publicado: (2018)

IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score
por: Tang, Yingdan, et al.
Publicado: (2022)

Evaluation of Wound Healing Following Surgical Extractions Using the IPR Scale
por: Yahya, Bahaa Haj, et al.
Publicado: (2021)

AUR1 and its pals: orchestration of intracellular rhizobia infection in legume for nitrogen fixation
por: Singh, Jawahar, et al.
Publicado: (2023)

Proposed design for the PGAA facility at the TRIGA IPR-R1 research reactor
por: Guerra, Bruno T, et al.
Publicado: (2013)

SnIPRE: Selection Inference Using a Poisson Random Effects Model
por: Eilertson, Kirsten E., et al.
Publicado: (2012)

Eu@C(72): Computed Comparable Populations of Two Non-IPR Isomers
por: Slanina, Zdeněk, et al.
Publicado: (2017)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Spindle assembly checkpoint inactivation fails to suppress neuroblast tumour formation in aurA mutant Drosophila
por: Caous, Renaud, et al.
Publicado: (2015)

pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer
por: Cao, Zhiwen, et al.
Publicado: (2020)

IPred - integrating ab initio and evidence based gene predictions to improve prediction accuracy
por: Zickmann, Franziska, et al.
Publicado: (2015)

Individual Patient Research (IPR) Outcomes with Alzheimer's Disease: The Psycho-neuro-immune Viewpoint
por: Chiappelli, Francesco, et al.
Publicado: (2016)

Probing flavoured Axions in the Tail of $B_q \to \mu^+\mu^-$
por: Albrecht, Johannes, et al.
Publicado: (2019)

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023)

Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation
por: Quattrini, Luca, et al.
Publicado: (2019)

The Use of Mycoendophyte-Based Bioformulations to Control Apple Diseases: Toward an Organic Apple Production System in the Aurès (Algeria)
por: Bensaci, Oussama A., et al.
Publicado: (2022)

Investigating the antimicrobial activity, cytotoxicity, and action mechanism of acylated and amidated derivatives of AurH1 antifungal peptide
por: Nikookar Golestani, Reyhane, et al.
Publicado: (2023)

A rapid surge of the Omicron variant’s sublineages BQ.1/BQ.1.1: A matter of worry amid the crucial trajectory of the COVID-19 pandemic
por: Dhawan, Manish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c1vesjl544h5hptjc4msuin5ba